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Abstract
Background: Galloway–Mowat syndrome (GAMOS) is a rare hereditary renal–neurological disease characterized by
early-onset steroid-resistant nephrotic syndrome in combination with microcephaly and brain anomalies. Recently,
novel causative mutations for this disease have been identified in the genes encoding the four KEOPS subunits:
OSGEP, TP53RK, TPRKB, and LAGE3.
Case presentation: We detected a novel homozygous TP53RK mutation (NM_033550, c.194A > T, p.Lys65Met) using
whole exome sequencing in a familial case of GAMOS with three affected siblings. All three patients manifested similar
phenotypes, including very early-onset nephrotic syndrome (8 days, 1 day, and 1 day after birth, respectively),
microcephaly, dysmorphic faces, and early fatality (10 months, 21 days, and 25 days of age, respectively). One patient
also showed hiatal hernia with gastric volvulus. Renal biopsy performed on one patient revealed focal segmental
glomerulosclerosis with severe tubulo-interstitial changes.
Conclusion: We report on a familial case of GAMOS with three affected siblings carrying a novel homozygous TP53RK
mutation. To our knowledge, this is only the second report on GAMOS in association with a TP53RK mutation.
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Background
Galloway-Mowat syndrome (GAMOS) is a rare hereditary
renal–neurological disease characterized by early-onset
steroid-resistant nephrotic syndrome combined with micro-
cephaly and brain anomalies [1, 2]. There have been several
reports of candidate genes for this disease, namely WDR73
[3–8], NUP107 [9], and WHAMM [10]. Recently, Hildeb-
randt and colleagues [11] identified novel causative muta-
tions in the genes encoding the four KEOPS (Kinase,
Endopeptidase and Other Proteins of small Size) subunits,
OSGEP, TP53RK, TPRKB, and LAGE3, in 37 individuals
from 32 families with GAMOS. They also revealed that
knocking down genes encoding KEOPS subunits in human
podocytes results in impaired cell proliferation, translational
attenuation, endoplasmic reticulum (ER) stress, activation of
DNA damage response (DDR) signaling, increased apop-
tosis, and defects in actin regulation, which are possible
pathogenic features of GAMOS [11]. Another study inde-
pendently reported a familial case of GAMOS with a homo-
zygous OSGEPmutation [12].
Here, we report the identification of a homozygous
TP53RK mutation in a familial case of GAMOS with
three affected siblings.
Case presentations
The parents of the patients were nonconsanguineous
and had four offspring (II-1–II-4), three of which exhib-
ited very similar phenotypes (Table 1). This study was
approved by the Seoul National University Hospital’s In-
stitutional Review Board (IRB No. 0812–002-264). In-
formed consent was obtained from the parents.
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Case II-1
This female baby was born after a gestational period of
39+ 3 weeks. The birth weight was 2250 g (< 3rd percent-
ile), height was 46 cm (5–10th percentile), head circum-
ference was 29 cm (< 3rd percentile), and the Apgar
scores at 1 and 5 min were 5 and 7, respectively. A dia-
phragmatic hernia was noted in the delivery room. The
initial serum albumin level at day one was 3.3 g/dL and
the initial serum creatinine level, which reflects the
mother’s renal function, was 0.58 mg/dL. Imaging re-
vealed a hiatal hernia with gastric volvulus (Fig. 1). She
also had facial dysmorphism including ocular hypertelor-
ism and low-set ears, and a brain magnetic resonance
image (MRI) revealed microcephaly with a simplified
Table 1 Clinical features of affected individuals
Case II-1 II-2 II-4
Gender Female Male Male
Age of death 10 months 21 days 25 days
Ethnicity Korean Korean Korean
Neonatal Profile
Gestational period (weeks) 39+ 3 36+ 6 36+ 4
Apgar score (5 min) 7 7 7
Pregnancy course fetal distress fetal distress, C/S fetal distress, C/S
Birth height (cm) 46 (5–10th percentile) 47.5 (10–25th percentile) 45 (3rd–5th percentile)
Birth weight (g) 2250 (< 3rd percentile) 1960 (< 3rd percentile) 1780 (< 3rd percentile)
Head circumference (cm) 29 (< 3rd percentile) 28 (< 3rd percentile) 27 (< 3rd percentile)
Renal Phenotypes
Onset of nephrotic syndrome 8 days 1 day 1 day
Renal biopsy (age) FSGS (2 weeks) NP NP


















C/S Caesarean section, MRI magnetic resonance imaging, NP not performed
Fig. 1 Upper gastrointestinal examination of Case II-1. Anteroposterior (a) and lateral (b) projections revealed an upward dislocation of the
stomach into the mediastinum, which is compatible with a hiatal hernia
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gyral pattern (Fig. 2a). Surgical repair of the hiatal hernia
was performed 6 days after birth without any serious
events. The baby started to feed on a mix of breast milk
and formula. Two days after surgery, generalized edema
developed with a decrease in urine volume. Serum albu-
min levels decreased to 2.0 g/dL, serum creatinine levels
increased to 1.29 mg/dL, and 24-h urinary protein excre-
tion was 2871 mg/day. Renal ultrasonography revealed in-
creased echogenicity of both kidneys with poor
differentiation between the peripheral cortex and central
echogenic complex. At the age of 2 weeks, an open kidney
biopsy was performed (Fig. 3). Thirty-eight (44%) of 87
glomeruli exhibited segmental lobular collapse and scler-
osis, and some of the nonsclerotic glomeruli showed fea-
tures of immature fetal glomeruli. Tubules displayed
severe focal atrophy and loss. Infiltration of mononuclear
cells and fibrosis were observed in the interstitium. A
follow-up brain MRI at 4 months of age showed the pro-
gression of diffuse brain atrophy with subarachnoid space
widening (Fig. 2b). Massive proteinuria persisted and
serum creatinine levels began to rise rapidly at the age of
9 months. However, the baby received conservative treat-
ment only, including intermittent albumin replacement,
because the parents did not want immunosuppressive
treatment or any other aggressive renal replacement ther-
apy. The baby died at the age of 10 months.
Case II-2
This male baby was born by cesarean section due to fetal
distress at the gestational age of 36+ 6 weeks. Birth
weight was 1960 g (< 3rd percentile), height was 47.5 cm
(10–25th percentile), head circumference was 28 cm (<
3rd percentile), and the Apgar scores at 1 and 5 min were
6 and 7, respectively. The baby displayed various features
of facial dysmorphism (microcephaly, almond-shaped eye,
abnormally high but narrow forehead, ocular hypertelor-
ism, depressed nasal bridge, large and low-set ears,
A B C
Fig. 2 Patients’ brain magnetic resonance images (MRIs). Axial T2-weighted MRI (a) of Case II-1 taken at 2 weeks of age shows a simplified gyral
pattern with too few and shallow sulci and normal cortical thickness. Follow-up axial T2-weighted MR image (b) acquired at 4 months of age
shows a progression of diffuse brain atrophy with subarachnoid space widening. Axial T2-weighted MRI (c) of Case II-2 obtained at 3 weeks of
age shows a similar pattern of simplified sulcation as the sibling. Note extensive fluid collection in the scalp (arrows)
A
B
Fig. 3 Renal pathological findings from Case II-1 at 2 weeks of age.
a About half of the glomeruli showed segmental sclerosis (arrows).
Hematoxylin and eosin staining, original magnification × 400. b
Ultrastructurally, the glomerular basement membranes exhibit
normal thickness, but show focal subendothelial widening
(arrowheads). No electron-dense deposits were found. Epithelial cell
foot processes show focal marked effacement (arrows). Original
magnification × 5000
Hyun et al. BMC Medical Genetics  (2018) 19:131 Page 3 of 6
micrognathia, and high-arched cleft palate), and skeletal
deformities (arachnodactyly and clasped thumb). Massive
proteinuria, hypoalbuminemia, and generalized edema
were noted immediately after birth. Renal ultrasonography
revealed bilaterally small echogenic kidneys with poor
cortico-medullary differentiation. A brain MRI revealed
microlissencephaly, small cerebellar hemisphere size, and
decreased volume of the ventral pons (Fig. 2c). At the age
of 15 days, serum albumin and creatinine levels were 2.6 g/
dL and 2.88 mg/dL, respectively. The parents did not want
any active treatment at this time, and the patient died at
the age of 21 days due to rapidly decreasing renal function.
Case II-3
Cases II-3 and II-4 were dizygotic twin babies born after
in vitro fertilization. They were born by cesarean section
after a gestational period of 36+ 4 weeks. The birth weight
of Case II-3 was 2830 g (10–25th percentile), height was
46 cm (5–10th percentile), and head circumference was
34 cm (25–50th percentile). Physical examination revealed
no abnormalities, and there were no perinatal or neonatal
problems. At the age of 6 weeks, serum albumin and cre-
atinine levels were 4.1 g/dL and 0.22 mg/dL, respectively.
Urinalysis revealed no proteinuria.
Case II-4
This male baby was the second of the dizygotic twins.
Intrauterine growth retardation was detected by fetal
ultrasonography. Birth weight was 1780 g (< 3rd per-
centile), height was 45 cm (3rd–5th percentile), head cir-
cumference was 27 cm (< 3rd percentile), and the Apgar
scores at 1 and 5 min were 4 and 7, respectively. He ex-
hibited ocular hypertelorism, micrognathia, and low-set
ears. A brain MRI revealed lissencephaly. Generalized
edema with massive proteinuria developed soon after
birth. Serum creatinine levels at 3 days and 7 days after
birth were 1.11 mg/dL and 1.27 mg/dL, respectively.
Renal ultrasonography performed at 1 week after birth
revealed small echogenic kidneys with poor differenti-
ation between the peripheral cortex and the central
echogenic complex. The patient was treated conserva-
tively and died 25 days after birth.
Mutational analyses
Whole exome sequencing was performed for Case II-2 as
previously described [13], which revealed a novel homozy-
gous c.194A >T (p.Lys65Met) mutation in exon 1 of the
TP53RK gene (NM_033550). This was later confirmed
using traditional Sanger sequencing. A study of all family
members using Sanger sequencing revealed that Case II-4
carried the same homozygous mutation, and that both par-
ents and Case II-3 were heterozygous for the mutation. Al-
though we were not able to test Case II-1 due to a lack of
available samples, her phenotypes were very similar to
those of the other two affected siblings who carried the
mutation.
Discussion and conclusions
GAMOS is a heterogeneous disease, both phenotypically
and genetically. Phenotypically, in addition to major find-
ings of early-onset nephrotic syndrome and microcephaly,
most patients have facial dysmorphia including hyperte-
lorism, ear abnormalities, and micrognathia. Some pa-
tients may present arachnodactyly, visual impairment, or
other manifestations [9].
Colin et al. [3] identified 2 different truncating muta-
tions in the WDR73 gene in 3 patients from 2 unrelated
families with GAMOS. The authors suggested that
WDR73 plays a role in regulating the microtubule net-
work during the cell cycle, and loss of its function leads
to impaired neuronal growth and brain development, as
well as impaired podocyte growth and maintenance in
the kidneys. After the investigation by Colin et al. [3],
several studies have reported on additional cases of
GAMOS in association with WDR73 mutations [4–8]. In
one of those studies [6], WDR73 mutations were found
in 3 (5.9%) of the 51 unrelated patients with cerebellar
atrophy and variable brain anomalies, and in 2 (5%) of
the 40 unrelated patients with a clinical diagnosis of
GAMOS. Rosti et al. [9] detected NUP107 mutations in
5 Turkish patients with GAMOS-like phenotypes from
two consanguineous families. However, in other reports
[14, 15], NUP107 mutations were associated with iso-
lated nephrotic syndrome. Therefore, there may be an
allele-specific critical role for NUP107 in regulating
brain growth and GAMOS-like presentation [9].
Recently, a large-scale study [11] identified novel causa-
tive mutations in one of the four genes encoding KEOPS
subunits, OSGEP, TP53RK, TPRKB and LAGE3, in 37 indi-
viduals (from 32 families) out of 91 individuals with
GAMOS. In that study, OSGEP mutations were the most
common, and were detected in 28 individuals from 24 fam-
ilies, while mutations in TP53RK were detected in only 4
individuals from 3 families. Almost half of the families car-
rying OSGEP mutations were of Taiwanese or East Asian
descent, while the Korean family described in the present
case study carried aTP53RKmutation. In addition, an inde-
pendent study [12] reported on a familial case of GAMOS
with OSGEP mutations. Currently, the five genetic subtypes
of GAMOS are listed in the Online Mendelian Inheritance
in Men (https://www.ncbi.nlm.nih.gov/omim/) database.
GAMOS1–5 are associated with mutations in WDR73,
LAGE3, OSGEP,TP53RK, and TPRKB, respectively. All sub-
types exhibit autosomal recessive inheritance, except for
GAMOS2, which exhibits X-linked recessive inheritance.
The TP53RK mutation identified in the present study
[i.e., c.194A > T (p.Lys65Met)] is novel. Co-segregation
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of the recessive mutation with the phenotype in the fam-
ily members, including both parents, was confirmed.
Interestingly, a known variation involving the same
Lys65 [i.e., c.194A > G (p.Lys65Arg)] has a reported al-
lele frequency of 0.00009747 (ExAC Browser, http://
exac.broadinstitute.org/). Although we did not perform
functional studies, both variations are predicted to be
pathogenic according to the web-based program Muta-
tionTaster (http://www.mutationtaster.org/). Whole ex-
ome sequencing performed for Case II-2 revealed no
pathogenic variants in other known candidate genes of
GAMOS, namely WDR73, NUP107, WHAMM, and
other genes encoding KEOPS subunits. In our whole ex-
ome sequencing pipeline, common nucleotide variants
(minor allele frequency > 1%) were removed in the mid-
dle of the analysis. The only variant in other known pro-
teinuria/focal segmental glomerulosclerosis-associated
genes, which was detected by the whole exome sequen-
cing, was a heterozygous c.449–26C > CT (rs35640989)
in the NUP107 gene. Although a mutational study for
Case II-1 was not performed owing to a lack of samples,
all the three affected babies included in this study
showed common manifestations of very early-onset
nephrotic syndrome, microcephaly, dysmorphic faces,
and early fatal outcome. Case II-1 had an additional
finding of a hiatal hernia with gastric volvulus. A hiatal
hernia was one of the features observed in the original
cases as reported by Galloway and Mowat [1]. However,
there have been only few case reports of GAMOS asso-
ciated with hiatal hernias, including one patient with
WDR73 mutations [6] and a familial case with OSGEP
mutations [11]. Case II-2 in the present study displayed
additional skeletal deformities, including arachnodactyly
and clasp thumb. Skeletal deformities are more com-
monly reported than hiatal hernias in patients with
GAMOS [11, 16–18]. In a large study conducted by
Braun et al. [11], most of the Taiwanese patients had ara-
chnodactyly and carried OSGEP mutations. All three pa-
tients in the present study had an early fatal outcome;
therefore, we could not evaluate long-term clinical
changes in growth and development. To date, only four
patients with GAMOS from three families have been re-
ported in association with TP53RK mutations [11].
Among those four patients, two sibling cases showed simi-
lar phenotypes to those of our patients, i.e., early-onset
proteinuria at 2 months of age in both cases, early fatal
outcome at 2.5 months and 11 months of age, respect-
ively, and facial dysmorphism with skeletal abnormalities
in one case. The other two patients showed relatively later
onset at 1 year and 10 months of age, respectively, and
later fatal outcomes at 2.5 years and 3 years of age,
respectively.
The KEOPS complex contains five subunits: LAGE3,
OSGEP, TP53RK, TPRKB, and the recently identified
C14orf142 [19]. Braun et al. [10] identified and meticu-
lously studied multiple mutations in the genes encoding
the four KEOPS subunits, including OSGEP, TP53RK,
TPRKB, and LAGE3. The authors conducted short hair-
pin RNA (shRNA)-mediated knockdown of KEOPS sub-
units and showed that mutations in OSGEP, TP53RK,
and TPRKB could not rescue proliferation defects in hu-
man podocytes, suggesting that these alleles impaired
protein functionality. Co-immunoprecipitation experi-
ments revealed that the p.Lys60Serfs*61 and p.Thr81Arg
mutations in TP53RK detected in a family abrogated the
interaction between TPRKB and TP53RK [11]. However,
other mutations in any of the four genes did not abrogate
intermolecular interactions. The canonical function of the
KEOPS complex is to mediate N6-threonylcarbamoylade-
nosine modifications, known as a t6A modification, at pos-
ition 37 of all tRNAs that recognize codons that start with
adenosine, i.e., ‘ANN codons’ [20–23]. Braun et al. [11]
demonstrated that knocking down OSGEP, TP53RK, or
TPRKB using shRNA in human podocytes resulted in
various effects, including decreased t6A levels, inhibition
of nascent protein synthesis, decreased cell proliferation,
activation of the unfolded protein response with ER stress,
upregulation of the ER-associated proteasomal degrad-
ation system, and increased apoptosis associated with acti-
vation of the DDR. Knockdown of one of these three
components of the KEOPS complex also disrupts the for-
mation of the sublamellar actin network in human podo-
cytes and decreases podocyte migration [11]. Therefore,
the authors concluded that mutations in the KEOPS com-
plex impair both the canonical and noncanonical func-
tions of the KEOPS complex, which would play a major
pathogenic role in the development of GAMOS [11].
In conclusion, we report a familial case of GAMOS as-
sociated with a novel homozygous TP53RK mutation
(p.Lys65Met). Three of the four children in the family
were affected and displayed similar phenotypes, including
very early-onset nephrotic syndrome, microcephaly, facial
dysmorphia, and early fatality. In addition, renal biopsy re-
vealed focal segmental glomerulosclerosis in one patient.
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